Ob/Gyn Department Meeting - May 12, 2017

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	0
Explain the clinical applications of fetal fibronectin (fFN) in asymptomatic vs symptomatic patients.	Explain the clinical applications of fetal fibronectin (fFN) in asymptomatic vs symptomatic patients. - 5	Explain the clinical applications of fetal fibronectin (fFN) in asymptomatic vs symptomatic patients. - 4	Explain the clinical applications of fetal fibronectin (fFN) in asymptomatic vs symptomatic patients. - 3	Explain the clinical applications of fetal fibronectin (fFN) in asymptomatic vs symptomatic patients. - 2	Explain the clinical applications of fetal fibronectin (fFN) in asymptomatic vs symptomatic patients. - 1	Explain the clinical applications of fetal fibronectin (fFN) in asymptomatic vs symptomatic patients. - 0
Implement strategies utilizing fFN to more accurately identify patients in preterm labor.	Implement strategies utilizing fFN to more accurately identify patients in preterm labor. - 5	Implement strategies utilizing fFN to more accurately identify patients in preterm labor. - 4	Implement strategies utilizing fFN to more accurately identify patients in preterm labor. - 3	Implement strategies utilizing fFN to more accurately identify patients in preterm labor. - 2	Implement strategies utilizing fFN to more accurately identify patients in preterm labor. - 1	Implement strategies utilizing fFN to more accurately identify patients in preterm labor. - 0
Improve accuracy when using quantitative fFN measurements to define risk of spontaneous preterm birth, particularly for asymptomatic women.	Improve accuracy when using quantitative fFN measurements to define risk of spontaneous preterm birth, particularly for asymptomatic women. - 5	Improve accuracy when using quantitative fFN measurements to define risk of spontaneous preterm birth, particularly for asymptomatic women. - 4	Improve accuracy when using quantitative fFN measurements to define risk of spontaneous preterm birth, particularly for asymptomatic women. - 3	Improve accuracy when using quantitative fFN measurements to define risk of spontaneous preterm birth, particularly for asymptomatic women. - 2	Improve accuracy when using quantitative fFN measurements to define risk of spontaneous preterm birth, particularly for asymptomatic women. - 1	Improve accuracy when using quantitative fFN measurements to define risk of spontaneous preterm birth, particularly for asymptomatic women. - 0
Apply management strategies and interventions for preterm birth to improve clinical outcomes.	Apply management strategies and interventions for preterm birth to improve clinical outcomes. - 5	Apply management strategies and interventions for preterm birth to improve clinical outcomes. - 4	Apply management strategies and interventions for preterm birth to improve clinical outcomes. - 3	Apply management strategies and interventions for preterm birth to improve clinical outcomes. - 2	Apply management strategies and interventions for preterm birth to improve clinical outcomes. - 1	Apply management strategies and interventions for preterm birth to improve clinical outcomes. - 0

Rate the following *

Scoring Key: 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor

	5	4	3	2	1
Course content.	Course content. - 5	Course content. - 4	Course content. - 3	Course content. - 2	Course content. - 1
Victor Gonzalez-Quintero, M.D., MPH	Victor Gonzalez-Quintero, M.D., MPH - 5	Victor Gonzalez-Quintero, M.D., MPH - 4	Victor Gonzalez-Quintero, M.D., MPH - 3	Victor Gonzalez-Quintero, M.D., MPH - 2	Victor Gonzalez-Quintero, M.D., MPH - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so. *

List topics related to this lecture that you want to learn more about?

Comments

Name

You are here

Ob/Gyn Department Meeting - May 12, 2017